Auryxia
Payments companies reported to CMS as associated with Auryxia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Auryxia, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Auryxia
These are the largest totals companies reported as associated with Auryxia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nimish Naik | Wexford, PA | Nephrology (Internal Medicine) | $10,860.59 |
| Wolfgang Winkelmayer | Houston, TX | Nephrology (Internal Medicine) | $9,417.57 |
| Sunil Patel | Apple Valley, CA | Nephrology (Internal Medicine) | $5,929.49 |
| Christopher Gisler | Pittsburgh, PA | Nephrology (Internal Medicine) | $5,714.33 |
| Anthony Portale | San Francisco, CA | Pediatrics | $4,572.00 |
| Gopa Green | Santa Rosa, CA | $3,315.00 | |
| Emmanuel Antonio | Wilmington, DE | Family | $2,599.14 |
| Rohit Pankhaniya | Port Charlotte, FL | Nephrology (Internal Medicine) | $2,455.97 |
| Karen Robertson | Greenville, SC | Adult Health (Nurse Practitioner) | $2,071.22 |
| Navid Saigal | Live Oak, TX | Nephrology (Internal Medicine) | $1,991.80 |
Prescribed Auryxia?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.